Results of clinical studies in children have shown that, on average, the younger the patients, the higher the NeoRecormon doses required.
Kliinilised uuringud lastel on näidanud, et mida noorem on laps, seda suuremat NeoRecormon´i annust tavaliselt vajatakse.